Remy Neville, MD

Dr. Remy Neville operates Medical Offices of Manhattan in New York, NY, providing integrative medical services with a focus on peptide-based weight management and metabolic optimization. The practice combines in-person consultations at its Manhattan location with telehealth appointments for New York State residents, allowing patients flexibility in how they access care. Dr. Neville's approach centers on evidence-based peptide therapies, particularly GLP-1 receptor agonists, which have demonstrated efficacy in appetite regulation and glycemic control for patients struggling with obesity and metabolic syndrome.

The clinic's peptide therapy protocols include GLP-1 medical weight loss pathways tailored to individual metabolic profiles, body composition analysis results, and health history. Dr. Neville prescribes semaglutide and tirzepatide for patients who meet clinical criteria, incorporating these medications into comprehensive programs that address nutrition, lifestyle modification, and metabolic health markers. Beyond weight management, the practice offers peptide therapies for patients seeking improvements in body composition, recovery from metabolic dysfunction, and optimization of insulin sensitivity. Each treatment plan begins with laboratory assessment of fasting glucose, hemoglobin A1c, lipid panels, and thyroid function to establish baseline metabolic status before initiating peptide protocols.

Dr. Remy Neville brings board-certified medical expertise to peptide therapy administration, with training in internal medicine and a clinical focus on metabolic disorders. The practice emphasizes patient education throughout treatment, ensuring individuals understand the mechanisms of action behind GLP-1 receptor agonists, expected timelines for results, and the importance of concurrent lifestyle interventions. Dr. Neville monitors patients through regular follow-up appointments—conducted either in the Manhattan office or via secure telehealth platforms—adjusting peptide dosing based on tolerance, side effect profiles, and progress toward metabolic goals. This physician-supervised model distinguishes the practice from wellness centers that may lack medical oversight for peptide administration.

Patients at Medical Offices of Manhattan typically begin with an initial consultation that includes medical history review, discussion of weight loss or metabolic goals, and determination of candidacy for peptide therapy. For those pursuing GLP-1 treatment, Dr. Neville orders baseline labs and reviews contraindications such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Once cleared for treatment, patients receive detailed injection training, prescription coordination, and a structured follow-up schedule. The practice's hybrid model means Manhattan-based patients can choose in-person visits for injection technique review or body composition assessments, while those with scheduling constraints or who live elsewhere in New York State can maintain continuity of care through video consultations.

With a 4.7-star rating across 13 Google reviews, Medical Offices of Manhattan has established a reputation among New York patients seeking physician-guided peptide therapy rather than protocol-driven wellness programs. The practice's telehealth capability extends access beyond Manhattan to patients throughout New York State who require medical supervision for GLP-1 therapies but cannot easily travel to the city. Dr. Neville's focus on metabolic health, combined with the flexibility of hybrid care delivery, positions the practice as a resource for patients who want peptide therapy integrated into a medically supervised framework rather than pursued as a standalone intervention. The clinic accepts new patients for both weight management and broader metabolic optimization consultations, with appointment availability for in-person and virtual visits.